peoplePerson
Laura J. Esserman
Breast surgeon who built the I-SPY platform, the adaptive trial that tests new drugs before surgery.
Laura Esserman is a breast surgeon and trial innovator. Esserman leads I-SPY 2, the adaptive neoadjuvant platform trial, and the WISDOM study of risk-based breast screening. A prominent voice on overdiagnosis and de-escalation.
Role
Director, UCSF Carol Franc Buck Breast Care Center; Principal Investigator, I-SPY trials
Specialisms
Breast cancerAdaptive trial designScreening
Profiles
| Title | Journal | Year |
|---|---|---|
| Adaptive Randomization of Neratinib in Early Breast Cancer | New England Journal of Medicine | 2016 |
| Rethinking screening for breast cancer and prostate cancer | JAMA | 2009 |